The company put out the extent of data it had available, Moderna Chairman Noubar Afeyan tells CNBC.
Moderna would never put out data on its potential vaccine for the coronavirus that was different from "reality," the biotech firm's chairman told CNBC.Scientist Xinhua Yan works in the lab at Moderna in Cambridge, MA on Feb. 28, 2020. Moderna has developed the first experimental coronavirus medicine, but an approved treatment is more than a year away.
, saying it did not provide critical information to assess its effectiveness. The report sent Moderna's stock and the broader U.S. market lower. The company put out the extent of data it had available, Moderna Chairman Noubar Afeyan said during an interview on " ." "We take what we do very seriously. We would not, have not put out some of the data to make anything look any different from the reality."on its potential vaccine, showing all 45 patients enrolled produced binding antibodies seen at similar levels of people who have recovered from the virus.
The vaccine produced neutralizing antibodies, which researchers believe is important to protect against the virus, for eight of the patients whose data was available so far. Data on neutralizing antibodies for the remaining patients are expected to come out later."That is not very useful to a world that is looking for some news that they can interpret," he said. "I would simply urge the public to pay attention to what we say.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Asia Pacific stocks set to open mixed as investors await release of China's benchmark lending rateInvestors will also watch for market reaction to a STAT News report released overnight that raised concerns about the trial results for a potential coronavirus vaccine from Moderna.
Read more »
Moderna says White House coronavirus vaccine chief is divestingFormer Moderna director Moncef Slaoui who now leads the White House's vaccine development effort will divest all of his equity interest, the company said.
Read more »
Asian stocks rise after Moderna's coronavirus vaccine delivers early positive results | Markets InsiderAsian stocks rose on Tuesday after Moderna reported promising results from the first human trials of its coronavirus vaccine. US futures slid af...
Read more »
Everything we know about Moderna's coronavirus vaccineModerna has been working closely with the National Institutes of Health since January to find a vaccine, including testing the vaccine on mice before moving on to human trials in March.
Read more »
White House coronavirus vaccine adviser Moncef Slaoui to divest $12.4 million of Moderna holdingsNewly appointed co-chair of the White House coronavirus vaccine project Moncef Slaoui plans to sell approximately $12.4 million worth of stock options in Moderna over the next 24 hours.
Read more »
Dow Falls 400 Points As Questions Are Raised Over Moderna’s Coronavirus VaccineThe Dow fell 400 points today as questions were raised over Moderna’s coronavirus vaccine by skleb1234
Read more »